Fate Therapeutics
FATE
#9041
Rank
โ‚ฌ90.1 M
Marketcap
0,79 โ‚ฌ
Share price
-3.66%
Change (1 day)
-88.44%
Change (1 year)

Revenue for Fate Therapeutics (FATE)

Revenue in 2024 (TTM): โ‚ฌ12.63 Million

According to Fate Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ12.62 Million. a decrease over the revenue in the year 2023 that were of โ‚ฌ57.47 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Fate Therapeutics from 2013 to 2024

201620192022โ‚ฌ20Mโ‚ฌ40Mโ‚ฌ60Mโ‚ฌ80Mโ‚ฌ0.1B0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 โ‚ฌ13.09 M-77.21%
2023 โ‚ฌ57.47 M-35.98%
2022 โ‚ฌ89.77 M82.05%
2021 โ‚ฌ49.31 M92.96%
2020 โ‚ฌ25.55 M168.06%
2019 โ‚ฌ9.53 M130.1%
2018 โ‚ฌ4.14 M21.08%
2017 โ‚ฌ3.42 M-18.23%
2016 โ‚ฌ4.18 M88.23%
2015 โ‚ฌ2.22 M
2014 N/A-100%
2013 โ‚ฌ0.7 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ1.76 B 13,853.33%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ19.10 B 151,319.56%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.74 B 5,818.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ10.08 M-20.06%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.18 B 17,179.00%๐Ÿ‡บ๐Ÿ‡ธ USA